tiprankstipranks
Nevro launches HFX iQ spinal cord stimulation system in the U.S.
The Fly

Nevro launches HFX iQ spinal cord stimulation system in the U.S.

Nevro has initiated the U.S. full market launch of its HFX iQ spinal cord stimulation – SCS – system, following the completion of a limited market release. HFX iQ combines clinical inputs, such as pain relief and pain score, along with Quality of Life inputs, such as pain medication and activity level changes, to provide an individualized program setting for each patient. The Senza high-frequency 10 kHz Therapy offers AI-driven iQ modes for treating painful diabetic neuropathy and chronic back and leg pain, including non-surgical back pain. In addition to the U.S. approval for Senza HFX iQ, Nevro has submitted for approval in Europe and Australia.

Published first on TheFly

See today’s best-performing stocks on TipRanks >>

Read More on NVRO:

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles